Bone mineral density optimisation in adults with perinatally acquired HIV infection in routine care
نویسندگان
چکیده
Puberty is a crucial time for bone development with a doubling of skeletal mass and at least 90% of bone mineral deposition accrued by the end of adolescence [1]. Following puberty, bone mineral deposition continues with peak bone mass typically obtained around the age of 25 years [2]. The accrual of bone mass during adolescence is a major determinant of peak bone mass [1] and low peak bone mass is associated with osteoporosis later in life [3].
منابع مشابه
Metabolic complications and treatment of perinatally HIV-infected children and adolescents
The benefits of long-term antiretroviral therapy (ART) are recognized all over the world with infected children maturing into adults and HIV infection becoming a chronic illness. However, the improved survival is associated with serious metabolic complications, including lipodystrophy (LD), dyslipidemia, insulin resistance, lactic acidosis and bone loss. In addition, the dyslipidemia mainly see...
متن کاملBrief Report: HIV Infection Is Associated With Worse Bone Material Properties, Independently of Bone Mineral Density.
Low bone mineral density (BMD) in HIV-infected individuals has been documented in an increasing number of studies. However, it is not clear whether it is the infection itself or the treatment that causes bone impairment. Microindentation measures bone material strength (Bone Material Strength index) directly. We recruited 85 patients, 50 infected with HIV and 35 controls. Median Bone Material S...
متن کاملBone Mineral Density and Cystic Fibrosis: A Review
Cystic fibrosis (CF) is a common progressive genetic disorder among children which involves lungs, kidneys, intestine and liver. Apart from the significance of genetic factors, various environmental factors particularly bone mineral density are directly associated with CF. Remarkably, bone disease is appeared as a routine and commo...
متن کاملBone disease in HIV infection.
The advent of highly active anti-retroviral therapy (HAART) has dramatically decreased the rate of AIDS-related mortality and significantly extended the life span of patients with AIDS.A variety of metabolic side effects are associated with these therapies, one of which is metabolic bone disease. The causes of low bone mineral density (BMD) in individuals with HIV infection appear to be multifa...
متن کاملLow bone mineral density with tenofovir: does statistically significant mean clinically significant?
Adults with human immunodeficiency (HIV) infection appear to have a greater prevalence of low bone mineral density (BMD) and of fractures than do adults without HIV infection [1,2]. HIV infection itself may contribute to this greater prevalence. HIV induces inflammation (a known association with accelerated BMD loss), and low BMD has been reported in individuals with untreated HIV infection [1,...
متن کامل